Exhibit 107
CALCULATION OF FILING FEE TABLES
Form S-3
(Form Type)
Stoke Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1 – Newly Registered Securities
| Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee | |||||||
| Equity | Common stock, par value $0.0001 per share |
Rule 457(c) |
10,843,681(2) | $14.87(3) | $161,245,536.47 | $0.0001476 | $23,799.85 | |||||||
| Total Offering Amounts | $23,799.85 | |||||||||||||
| Total Fee Offsets | — | |||||||||||||
| Net Fee Due | $23,799.85 | |||||||||||||
| (1) | Represents the shares of Common Stock, par value $0.0001 per share (the “Common Stock”) of Stoke Therapeutics, Inc. (the “Registrant”) that will be offered for resale by the selling stockholders pursuant to the prospectus to which this exhibit is attached. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of additional shares of Common Stock as may be issuable as a result of stock splits, stock dividends or similar transactions with respect to the shares being registered hereunder. |
| (2) | Consists of an aggregate of 10,843,681 shares of the Registrant’s Common Stock. |
| (3) | Estimated in accordance with Rule 457(c) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $14.87, the average of the high and low prices of the Common Stock as reported on The Nasdaq Global Select Market on June 7, 2024. |